Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Cleared to Open Medical Marijuana Dispensaries in Pennsylvania

By Eric Volkman – Feb 21, 2020 at 3:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company must also support research activities after being awarded Clinical Registrant status by the state.

Curaleaf Holdings (CURLF 33.12%) has been designated a Clinical Registrant in Pennsylvania, both the company and the state announced in separate press releases late this week. This status will allow Curaleaf to open as many as six cannabis dispensaries there, plus one growth and production facility. 

Curaleaf was one of four marijuana companies that received the designation from the state this week. Three other entities had already been given it, with one more yet to be announced.

The Liberty Bell in Philadelphia.

Image source: Getty Images

Pennsylvania runs a research program on the use and effects of marijuana, which it legalized solely for medical use in 2016. Its Clinical Registrant designation is unique among U.S. states. While those companies given the designation are permitted to operate cultivation and production facilities as well as dispensaries, they must be also contracted with an academic clinical research center approved by the state, and support their partner center's research. In Curaleaf's case, it is partnered with The Perelman School of Medicine at the University of Pennsylvania in Philadelphia.

The state's Department of Health began this research program last summer, at which point it named the first three Clinical Registrants. According to the department, nearly 289,000 patients and caregivers take part in Pennsylvania's medical cannabis program. In order to qualify, patients must be diagnosed with one of 23 designated medical conditions. At the moment, they are served by 77 licensed dispensaries and 21 entities that hold cultivation and processing permits.

In spite of the news, Curaleaf's stock was down slightly in mid-afternoon trading Friday.


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$6.19 (33.12%) $1.54

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.